Show simple item record

dc.contributor.advisorSundaresan, N Ravi
dc.contributor.authorSubramanian, Veena
dc.date.accessioned2018-01-10T02:30:29Z
dc.date.accessioned2018-07-30T14:23:32Z
dc.date.available2018-01-10T02:30:29Z
dc.date.available2018-07-30T14:23:32Z
dc.date.issued2018-01-10
dc.date.submitted2016
dc.identifier.urihttps://etd.iisc.ac.in/handle/2005/3000
dc.identifier.abstracthttp://etd.iisc.ac.in/static/etd/abstracts/3865/G28304-Abs.pdfen_US
dc.description.abstractCardiovascular diseases are one of the leading causes of mortality. A common denominator across most of the cardiovascular diseases like diabetic cardiomyopathy, hypertrophic cardiomyopathy, myocardial infarction and dilated cardiomyopathy is the pathological remodelling of heart leading to fibrosis. Cardiac fibrosis is characterized by the excessive production and deposition of extracellular matrix components due to unwarranted proliferation of fibroblasts. Under normal conditions, following cardiac remodelling, my fibroblasts undergo programmed cell death. However, this does not happen under pathological conditions ultimately leading to fibrosis. Although the molecular events and signalling pathways that contribute to the development of cardiac fibrosis is well established, there are limited studies which try to understand the mechanisms by which fibroblasts persist and resist programmed cell death. Here we demonstrate that SIRT6, one of the members of sirtuin family of histone deacetylases, plays an important role in regulating my fibroblast cell death. When we analysed the mice hearts and isolated fibroblasts deficient in SIRT6, we observed increased expression of my fibroblast markers, suggesting that SIRT6 deficient hearts might have a high proportion of resident my fibroblasts. Also, when SIRT6 deficient fibroblasts were subjected to genotoxic stress, they showed reduced cell death and impaired mitochondrial to nuclear AIF translocation as compared to WT controls. An important regulator of AIF mediated cell death is the protein PARP-1. When we checked the expression levels of this protein under SIRT6 deficient conditions, it was found to be low. PARP-1 was also found to degrade faster under SIRT6 deficient conditions. Further qPCR analysis revealed that the transcript levels of PARP-1 were unaffected by SIRT6 suggesting that the regulation might not be at the transcriptional level. When we studied the acetylation of PARP-1 under SIRT6 deficient conditions we found the protein to be hypo-acetylated indicating a more complex mechanism of regulation.en_US
dc.language.isoen_USen_US
dc.relation.ispartofseriesG28304en_US
dc.subjectCardial Fibrosisen_US
dc.subjectSirtuinsen_US
dc.subjectSIRT6en_US
dc.subjectMyofibroblast Cell Deathen_US
dc.subjectHistone Deacetylasesen_US
dc.subjectPoly(ADP-Ribose)Polymerase 1-PARP 1en_US
dc.subjectFibroblastsen_US
dc.subjectFibrosisen_US
dc.subject.classificationMicrobiology and Cell Biologyen_US
dc.titleRole of SIRT6 in Myofibroblast Cell Deathen_US
dc.typeThesisen_US
dc.degree.nameMSen_US
dc.degree.levelMastersen_US
dc.degree.disciplineFaculty of Scienceen_US


Files in this item

This item appears in the following Collection(s)

Show simple item record